Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,381 to 1,400 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epitranscriptomic regulation of cortical neurogenesis via Mettl8-dependent mitochondrial tRNA m3C modification. | Cell Stem Cell | 2023 | 36764294 | PubTator, text mining | PubMed |
| Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4. | Cell Cycle | 2023 | 36762777 | PubTator, text mining | PubMed |
| Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer. | Front Immunol | 2023 | 36761737 | PubTator, text mining | PubMed |
| Heterogeneous Nuclear Protein U Degraded the m6A Methylated TRAF3 Transcript by YTHDF2 To Promote Porcine Epidemic Diarrhea Virus Replication. | J Virol | 2023 | 36752613 | PubTator, text mining | PubMed |
| The chromatin-associated RNAs in gene regulation and cancer. | Mol Cancer | 2023 | 36750826 | PubTator, text mining | PubMed |
| Comprehensive analysis of prognosis of patients with GBM based on 4 m6A-related lncRNAs and immune cell infiltration. | Heliyon | 2023 | 36747529 | PubTator, text mining | PubMed |
| Methyltransferase-like 3 aggravates endoplasmic reticulum stress in preeclampsia by targeting TMBIM6 in YTHDF2-dependent manner. | Mol Med | 2023 | 36747144 | PubTator, text mining | PubMed |
| Metal Exposure Promotes Colorectal Tumorigenesis via the Aberrant N6-Methyladenosine Modification of ATP13A3. | Environ Sci Technol | 2023 | 36745568 | PubTator, text mining | PubMed |
| m6A Modification Mediates Endothelial Cell Responses to Oxidative Stress in Vascular Aging Induced by Low Fluid Shear Stress. | Oxid Med Cell Longev | 2023 | 36743697 | PubTator, text mining | PubMed |
| Identification of m6a-related signature genes in esophageal squamous cell carcinoma by machine learning method. | Front Genet | 2023 | 36733344 | PubTator, text mining | PubMed |
| Genome-wide deposition of 6-methyladenine in human DNA reduces the viability of HEK293 cells and directly influences gene expression. | Commun Biol | 2023 | 36732350 | PubTator, text mining | PubMed |
| METTL3 regulates breast cancer-associated alternative splicing switches. | Oncogene | 2023 | 36725888 | PubTator, text mining | PubMed |
| SLERT, as a novel biomarker, orchestrates endometrial cancer metastasis via regulation of BDNF/TRKB signaling. | World J Surg Oncol | 2023 | 36721236 | PubTator, text mining | PubMed |
| The miR-27a-3p/FTO axis modifies hypoxia-induced malignant behaviors of glioma cells. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 36718644 | PubTator, text mining | PubMed |
| Molecular mechanisms of environmental exposures and human disease. | Nat Rev Genet | 2023 | 36717624 | PubTator, text mining | PubMed |
| FTO-dependent m6A modification of Plpp3 in circSCMH1-regulated vascular repair and functional recovery following stroke. | Nat Commun | 2023 | 36717587 | PubTator, text mining | PubMed |
| New insights on the interaction between m6A modification and non-coding RNA in cervical squamous cell carcinoma. | World J Surg Oncol | 2023 | 36710350 | PubTator, text mining | PubMed |
| ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation. | Sci Rep | 2023 | 36709331 | PubTator, text mining | PubMed |
| Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma. | Eur J Med Res | 2023 | 36707911 | PubTator, text mining | PubMed |
| The potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancer. | Cell Death Discov | 2023 | 36707507 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=70